Could
Compound in Red Wine Help Cancer Patients?
Resveratrol Being Tested For Effectiveness
in Treatment and Prevention of Cancer
For
years, consumers and natural health advocates have been convinced
of the benefits of resveratrol, the healthy by-product of red-wine
grapes, but recently, the National Cancer Institute decided
it was time to investigate further.
Teaming with a leading biotech firm, the National Cancer Institute
is out to evaluate how derivatives of resveratrol can potentially
impede cancer cell development. Human studies have just started,
so conclusive evidence is not yet in hand. Still expert observers
are intrigued.
“There is an abundance of very well done basic preclinical
science to suggest a central role for resveratrol to reduce
inflammation and potentially have a role in cancer and heart
disease prevention and treatment,” said Bryan C. Donohue,
M.D., F.A.C.C., Chief, Division of Cardiology, University of
Pittsburgh Medical Center – Shadyside Hospital. “The
funding by the National Cancer Institute of studies to examine
the potential benefit of resveratrol among cancer patients points
out the importance of this intriguing molecule. Important early
stage clinical trials are now underway examining resveratrol’s
effectiveness among patients with heart disease, cancer, dementia
and a host of other modern plagues.”
In the meanwhile, many individuals simply looking for greater
energy, enhanced clarity of thought and advanced overall well
being are already benefiting from resveratrol supplementation,
according to Dr. Donohue.
“I have had occasion to introduce hundreds of patients
to daily resveratrol supplementation, ranging from healthy adults
interested in health maintenance and prevention to more elderly
individuals with specific health concerns,” Dr. Donohue
said. “The experience to date has been very gratifying.
People have experienced greater energy, increased exercise tolerance,
crispness and clarity of thought and a general bounce in their
overall level of well-being. Simply feeling vividly well is
a great way to begin the important campaign of achieving improved
health.”
“There are a wide variety of resveratrol products on the
market, and many of them include low concentrations of the ingredient
or they are of poor quality,” Dr. Donohue said. “I
recommend to my patients resveratrol supplements that have a
high concentration of the ingredient. I prefer the product line
from Vinomis (www.vinomis.com),
because their products contain a concentration of 98 percent
resveratrol plus pure red wine grape concentrate, and their
Web site is an outstanding resource for independent studies
and scientific information about natural compounds. My feeling
is that patients who are well-educated about their health options
make better choices.”
About Dr. Bryan Donohue
Dr. Bryan Donohue is the Chief of Cardiology, University of
Pittsburgh Medical Center – Shadyside Hospital, President
and Founder, Donohue Cardiology Associates and has been a Medical
Director at the Cardiac Cath Lab, UPMC. He graduated from Georgetown
Medical School 30 years ago, and has authored and co-authored
more than 20 medical research articles about angioplasty in
acute myocardial infarction.
For more information on Vinomis products or to interview Dr.
Bryan Donohue please contact Rachel Friedman at 727-443-7115
ext 206 or email Rachel@newsandexperts.com.
Please
include your name, publication and mailing address with your
request.